November 08, 2012
2 min read
Save

African-American women with HIV/HCV less prone to liver-related death than Caucasians, Hispanics

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

African-American women had a lower risk for liver-related death compared with Caucasians and Hispanics within a cohort of HIV/HCV coinfected patients in a recent study.

Researchers evaluated 794 coinfected women, including 140 Caucasians, 159 Hispanics and 495 African-Americans. All patients had been enrolled in the Women’s Interagency HIV Study. Incidence of all-cause and liver-related mortality within this cohort was recorded.

Death occurred in 438 cases, including 49 liver-related deaths, in 56.4% of the Caucasian participants, 55.8% of the Africa-Americans and 52.2% of the Hispanic patients during a median follow-up of 8.9 years. The most common causes of death included HIV/AIDS (36.9% of cases), liver-related illness (11.2%) and homicide, suicide or accident (9.0%).

Liver disease was the primary cause of mortality for 20.5% of Hispanics, 13.9% of Caucasians and 7.6% of African-Americans who died during the study. Investigators observed a significant difference between liver-related mortality rates among African-American patients and those of Caucasian (HR=0.41; 95% CI, 0.19-0.88) and Hispanic participants (HR=0.38; 95% CI, 0.19-0.76). The reduction in risk remained for African-American patients after adjusting for cardiovascular (HR=0.44, 0.20-0.95 compared with Caucasians; HR=0.39, 0.19-0.80 vs. Hispanics), HIV-related (HR=0.41, 0.19-0.88 vs. Caucasians; HR=0.38, 0.19-0.76 vs. Hispanics) and liver-related risk factors (HR=0.46, 0.22-0.98 vs. Caucasians; HR=0.43, 0.22-0.87 vs. Hispanics) (95% CI for all).

Rates of all-cause mortality were not significantly different between the groups (P=.8), and liver-related mortality rates were similar between Caucasian and Hispanic patients. Competing-risks and survival analyses also indicated that non-liver-related mortality risk was similar between African-Americans, Hispanics and Caucasians.

“We observed novel, important racial/ethnic trends in this large cohort of HIV/HCV coinfected women,” the researchers concluded. “Compared to Hispanic and Caucasian coinfected women, African-American coinfected women were much less likely to die from liver-related disease, which did not appear to be the result of differential classification of cause of death. Previous data have revealed racial/ethnic differences in immunologic response to HCV, which may affect rates of liver fibrosis. Future studies incorporating fibrosis progression may help us to better understand these marked racial/ethnic discrepancies in liver-related mortality.”